Skip to content
Draft Logo Final Draft Capital
  • HOME
  • SERVICES
    • INVESTMENT MANAGEMENT
    • CONSULTING
  • CLIENT PORTAL

Posts Tagged ‘restoration’

FDA approves VIZZ eye drops for presbyopia relief

By Matt Monson | August 7, 2025 | 0

VIZZ eye drops offer up to 10 hours of clear near vision for presbyopia sufferers, approved by FDA, available soon in the US. — Read on newatlas.com/aging/age-related-near-sighted-drops-vizz/

Read More

CRISPR Trial Provides Hope for Inherited Blindness – Neuroscience News

By Matt Monson | November 10, 2024 | 0

A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.— Read on neurosciencenews.com/crispr-genetics-vision-blindness-26038/

Read More

Lifechanging new eye drops can make reading glasses obsolete – The Brighter Side of News

By Matt Monson | November 10, 2024 | 0

Presbyopia is a common eye condition that affects people after the age of 40 and occurs when the lens of the eye loses its flexibility— Read on www.thebrighterside.news/health/lifechanging-new-eye-drops-can-make-reading-glasses-obsolete/

Read More

New Research Reveals How Our Eyes “Dance” for Clearer Vision

By Matt Monson | November 10, 2024 | 0

New Research Reveals How Our Eyes “Dance” for Clearer Vision— Read on scitechdaily.com/new-research-reveals-how-our-eyes-dance-for-clearer-vision/

Read More

Recent Posts

  • FDA approves VIZZ eye drops for presbyopia relief
  • 100-fold improvement in sight seen after gene therapy trial
  • Noninvasive imaging-guided ultrasonic neurostimulation with arbitrary 2D patterns and its application for high-quality vision restoration | Nature Communications
  • CRISPR Trial Provides Hope for Inherited Blindness – Neuroscience News
  • Nearsightedness Rates Are Soaring. Here’s Why | Scientific American

Recent Comments

    Archives

    • August 2025
    • November 2024
    • March 2024
    • November 2023

    Categories

    • Investor
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2022 DRAFT CAPITAL LLC
    Legal Disclaimer | Sitemap | Privacy Policy
    Facebook Linkedin